Roche therapy reduces risk of invasive breast cancer returning -trial - Reuters UK

Roche therapy reduces risk of invasive breast cancer returning -trial Reuters UK ZURICH, June 5 Roche Holding said a late-stage clinical trial had shown its Perjeta-based regimen reduced the risk of invasive cancer returning compared to standard therapy in a kind of early breast cancer. A combination of Perjeta, Herceptin and ... and more »

from Health - Google News http://ift.tt/2qTLe4c